SNCA and Parkinson disease: published a study demonstrating that germ free alpha-synuclein overexpressing (ASO) mice showed reduced pathology at 14 months, whereas ASO mice harboring bacteria isolated from PD patients showed earlier symptom onset and enhanced pathology [24].